Korean vs US Sunscreen: What the Evidence Actually Shows

Key points

• Korean sunscreens can legally use UV filters the US did not allow until recently. Bemotrizinol became a permitted US filter on 9 August 2026; other filters used abroad are still not US-approved as far as we could verify. [1][2]
• “SPF 50 PA++++” is a label, not a measurement. In Consumer Reports’ small 2026 test, three Korean formulas beat their US counterparts, but one measured SPF 36 against a label of “50+”. [3]
• The strongest evidence that sunscreen helps comes from one Australian trial (Nambour, 1,621 adults). It tested a US-style SPF 15+ product, not a Korean one. [4][5][6]
• The FDA-run absorption trials showed that common filters reach the blood. They did not show harm. [7][8]
• Verdict on the S-tier claim: partly supported. Daily sunscreen has real evidence behind it. “Korean” and “PA++++” add less than the ranking implies.

What the claim says

A tier list posted by @Hoostethics on X ranks “Korean SPF 50 PA++++ sunscreen” in S tier, next to tazarotene cream and other topicals [9]. The list gives no test data. We cover the other S-tier items in tazarotene vs tretinoin and in a wider check of looksmaxxing tier lists.

Why the filters differ

In the US, sunscreen is a nonprescription drug. An ingredient can be sold only if the FDA’s sunscreen monograph (M020) lists it. Consumer Reports notes that overseas regulators treat sunscreens as cosmetics, so brands can use a wider set of filters. [3]

Bemotrizinol shows how slow the US route was. DSM Nutritional Products asked for it on 23 September 2024. The FDA proposed it on 11 December 2025 and issued final order OTC000039 on 10 June 2026. [1][10] The order allows up to 6% in sunscreens for adults and children aged six months and older, requires a finished-product SPF of at least 2, and took effect on 9 August 2026. It also gives DSM exclusive marketing rights for 18 months. The FDA found the company’s aerosol-spray data insufficient, so the order does not cover aerosol sprays. [1] The FDA release said bemotrizinol “has been marketed as a sunscreen ingredient in many countries.” [10]

The wider picture, from the FDA’s question-and-answer page:

Filter group	FDA status (page read 2026-11-09)
Zinc oxide, titanium dioxide	Proposed as safe and effective, up to 25%
12 older filters, including avobenzone, oxybenzone, octinoxate, octocrylene	Proposed as “not GRASE” pending more data; the FDA says this is not a finding that they are unsafe
PABA, trolamine salicylate	Removal order issued 10 September 2026
Bemotrizinol	Added, effective 9 August 2026

[2] The 2021 proposed order (OTC000008) that would set these categories is still described as a proposal, and the bemotrizinol order says it does not finalize it. [1][2]

What we could not verify: the FDA pages we opened do not discuss bisoctrizole, drometrizole trisiloxane or terephthalylidene dicamphor sulfonic acid. A 2025 review says these filters are used internationally and not available in the US. [11] A 2026 letter in the Journal of the American Academy of Dermatology compares US and Korean filters, but we could not open it. Korea’s own filter list and the EU, UK and German registers were not checked.

What SPF and PA measure

SPF is mostly a UVB number. The standard in vivo method, ISO 24444:2019, applies the product at 2 mg/cm² and compares the dose that reddens protected skin with the dose that reddens unprotected skin. [12]

PA is a Japanese UVA grade (PA+ to PA++++) based on persistent pigment darkening. Japan’s cosmetics industry association says its method follows ISO 24442. [13] We could not open a primary source for the numeric ranges behind each plus sign, so we do not state them. The EU asks for a UVA protection factor of at least one third of the labelled SPF, with ISO 24443 as an example in vitro method. [12] The US uses a critical-wavelength test that gives pass or fail. [12]

Two points about these labels:

• Test-to-test scatter is large. In a multicentre study, 32 products went to 12 laboratories, and variability between laboratories rose with SPF. The authors called it “considerable” and likely larger than the public or regulators expect. [14] A statistical review found that two independent 10-subject ISO 24444 results for the same product can differ by a factor of up to 1.73 and still count as the same. [15]
• SPF and UVA do not move together. A 2026 study measured UVA protection (ISO 24442) in 38 sunscreens labelled SPF 50 or 50+ from Europe, Latin America, Oceania and Asia. UVA protection factors ranged from 3.6 to 46.6, and 26 of 38 (68%) met the EU ratio. The authors saw no relationship between SPF and UVA-PF values. [16] The abstract does not name the funder, and we could not check which products carried a PA rating.

Independent test results

Consumer Reports published “Does Korean Sunscreen Work Better?” on 10 July 2026. It tested six facial sunscreens from three brands, each brand’s Korean formula against its US formula. SPF was measured on three people, fewer than the FDA protocol calls for. UVA was measured on plates and scored on a graded scale. [3]

Pair	Korean: label / tested SPF	US: label / tested SPF
A	50+ / 36	50 / 19
B	50+ / 48	36 / 16
C	50+ / 46	50+ / 16

Consumer Reports said all three Korean formulas protected better than their US counterparts, but it said the test was small and that it “can’t claim” a definitive answer. It gave the Korean formulas no overall rating because they do not meet FDA rules. The Korean formulas carried PA++++. [3] The article also says one Korean formula contains bemotrizinol among several filters. [3]

Two readings fit these numbers. The Korean formulas were stronger on average. And a “50+” label did not guarantee a result near 50. Stiftung Warentest also tests sunscreens, but we could not open a current test report, so we make no claim about it.

Does sunscreen work at all?

The Nambour trial in Queensland randomised 1,621 adults to daily or discretionary sunscreen on head, neck, arms and hands from 1992 to 1996.

• Skin cancer, 4.5 years (Lancet, 1999). No difference in first basal-cell or squamous-cell cancers. Squamous-cell tumours counted by number were lower with daily sunscreen (rate ratio 0.61, 95% CI 0.46 to 0.81). The product was SPF 15 or higher. [4]
• Melanoma, 10 years after the trial (J Clin Oncol, 2011). 11 melanomas in the daily group, 22 in the discretionary group (HR 0.50, 95% CI 0.24 to 1.02, P = 0.051). Invasive melanoma: 3 versus 11 (HR 0.27, 95% CI 0.08 to 0.97). The headline result just missed significance, and melanoma was not the original primary outcome. [5][17]
• Photoaging (Ann Intern Med, 2013). In 903 adults under 55, skin aging after 4.5 years was 24% less with daily sunscreen (relative odds 0.76, 95% CI 0.59 to 0.98). The authors cited missing data and modest power. Funder: Australia’s National Health and Medical Research Council. [6]

None of this compares Korean and US products. It supports sunscreen use in general.

Safety evidence on filters

The FDA’s 2019 and 2020 trials were run to answer whether filters enter the bloodstream.

• 2019, JAMA: 24 healthy adults, four products, 2 mg/cm² on 75% of body surface, four times a day for four days. Avobenzone, oxybenzone, octocrylene and ecamsule all exceeded 0.5 ng/mL, the FDA’s threshold for considering extra toxicology studies. Oxybenzone reached about 170 to 210 ng/mL. [7]
• 2020, JAMA: 48 healthy adults, four formats (lotion and three sprays), six filters. All exceeded 0.5 ng/mL, in some cases after one application. Rash was the most common adverse event (14 participants). [8]

Both papers state that the results do not indicate people should stop using sunscreen. They measured blood levels, not outcomes. The 0.5 ng/mL line is a trigger for further study, not a safety limit. [7][8] This is the reason the FDA lists 12 older filters as needing data. Filters sold abroad have often passed other regulators’ reviews. We did not read those reviews. For bemotrizinol, the FDA’s own summary says low absorption and rare irritation. [10]

Risks and unknowns

• Imported formulas are not legal US products. Consumer Reports notes that buyers risk confiscation at the border. [3]
• Long-term human outcomes for most filters, in either market, are not covered by randomised trials.
• Absorbed filters have unknown clinical effects; the trials were short, in healthy adults, under maximal use. [7][8]
• No systematic review of Korean versus US products exists in what we opened. Consumer Reports’ test covered six products and three SPF volunteers per product. [3]
• UVA labels (PA, EU ratio, US pass or fail) are not equivalent, and we could not verify the PA numeric thresholds. [12][13]

Verdict on the S-tier claim

Partly supported. Daily sunscreen has randomised evidence for fewer squamous-cell tumours, a possible melanoma reduction and slower photoaging. A Korean formula with newer filters plausibly gives better UVA coverage, and one small blinded-label test agrees. But “Korean SPF 50 PA++++” describes a label, labels varied from measured values by up to 31 SPF points in that test, and no trial links PA++++ to better outcomes. The ranking has no source.

Frequently asked questions

Why can Korean sunscreens use filters the US lacks? The US regulates sunscreen as a drug and only the FDA’s monograph list is allowed. The FDA added bemotrizinol in 2026; other filters used abroad were not added in the orders we read. [1][2]

Does PA++++ mean better protection than SPF 50? They measure different things: SPF is mainly UVB, PA is a UVA grade. A 2026 study of 38 SPF 50 or 50+ products found UVA protection varied widely and did not track SPF. [16]

Do sunscreen filters get into the blood? Yes. Two FDA-run trials in 24 and 48 healthy adults found all tested filters above 0.5 ng/mL under maximal use. The authors said this does not mean people should avoid sunscreen. [7][8]

Is bemotrizinol available in US sunscreens now? It became a permitted filter on 9 August 2026, with 18 months of exclusive marketing rights for DSM. We did not check which products contain it. [1]

Sources

1. U.S. FDA, “Final Administrative Order (OTC000039), Amending Over-the-Counter Monograph M020” (issued 10 June 2026, corrected 10 August 2026). https://www.accessdata.fda.gov/drugsatfda_docs/omuf/Order/OTC000039_Final_Administrative_Order.pdf
2. U.S. FDA, “Questions and Answers: FDA’s regulatory actions on over-the-counter sunscreen” (read 2026-11-09). https://www.fda.gov/drugs/understanding-over-counter-medicines/questions-and-answers-fdas-regulatory-actions-over-counter-sunscreen
3. Consumer Reports, “Does Korean Sunscreen Work Better?” (10 July 2026). https://www.consumerreports.org/health/sunscreens/does-korean-sunscreen-work-better-a2100639078/
4. Green A et al., Lancet, “Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin” (1999). PMID 10475183, read via Europe PMC.
5. Green AC et al., J Clin Oncol, “Reduced melanoma after regular sunscreen use: randomized trial follow-up” (2011). PMID 21135266, read via Europe PMC.
6. Hughes MCB et al., Ann Intern Med, “Sunscreen and prevention of skin aging: a randomized trial” (2013). PMID 23732711, read via Europe PMC.
7. Matta MK et al., JAMA, “Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients” (2019). PMID 31058986, read via Europe PMC.
8. Matta MK et al., JAMA, “Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients” (2020). PMID 31961417, read via Europe PMC.
9. @Hoostethics on X, post of 2026-11-01. https://x.com/Hoostethics/status/2116976569034092805 . X returned an error and the fxtwitter mirror gave only a summary. The S-tier sunscreen wording is from the same account’s topical skincare tier list of 2026-10-19, as transcribed in our source notes; we could not open that post. ; original topical skincare tier list of 2026-10-19: https://x.com/Hoostethics/status/2112214865779806696
10. U.S. FDA, “FDA Proposes Expanding Sunscreen Active Ingredient List” (11 December 2025). https://www.fda.gov/news-events/press-announcements/fda-proposes-expanding-sunscreen-active-ingredient-list
11. “Modernizing U.S. Sunscreen Regulations: How Newer Filters Can Improve Public Health,” Photodermatol Photoimmunol Photomed (2025), abstract. PMID 40778531, read via Europe PMC.
12. “Global Perspectives on Regional Sun Protection Factor (SPF) Requirements,” Cureus (17 February 2026). https://pmc.ncbi.nlm.nih.gov/articles/PMC13000865/
13. Japan Cosmetic Industry Association, UV protection guideline page. https://www.jcia.org/home/business/guideline/uvprotection.html
14. “The variability of in vivo sunscreen sun protection factor values,” Int J Cosmet Sci (2025). PMID 40637051, abstract via Europe PMC.
15. “Determining the ability to differentiate results between independent sun protection factor tests using the ISO24444 method,” Front Med (2023). PMID 36891187, abstract via Europe PMC.
16. Young A et al., “In Vivo Measurement of UVA Protection Factor (ISO 24442:2011) Across 38 Different SPF 50 and SPF 50+ Sunscreens,” Photodermatol Photoimmunol Photomed (2026). PMID 41968398, abstract via Europe PMC.
17. Wehner MR, “Sunscreen and melanoma prevention: evidence and expectations,” Br J Dermatol (2018). https://pmc.ncbi.nlm.nih.gov/articles/PMC6009843

This article is information, not medical advice.